Keebeck Alpha, LP Exscientia PLC Transaction History
Keebeck Alpha, LP
- $150 Million
- Q3 2024
A detailed history of Keebeck Alpha, LP transactions in Exscientia PLC stock. As of the latest transaction made, Keebeck Alpha, LP holds 91,809 shares of EXAI stock, worth $444,355. This represents 0.3% of its overall portfolio holdings.
Number of Shares
91,809Holding current value
$444,355% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding EXAI
# of Institutions
85Shares Held
29.5MCall Options Held
500Put Options Held
189K-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$27.5 Million0.13% of portfolio
-
Laurion Capital Management LP New York, NY4.47MShares$21.6 Million0.3% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
-
Mic Capital Management Uk LLP London, X01.54MShares$7.47 Million1.14% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $593M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...